journal
MENU ▼
Read by QxMD icon Read
search

Journal of Oncology Pharmacy Practice

journal
https://www.readbyqxmd.com/read/28791909/it-takes-a-village-to-raise-awareness-of-and-to-address-surface-contamination-of-hazardous-drugs
#1
William C Zamboni, Stephanie A Salch, Joshua Cox, Stephen Eckel
No abstract text is available yet for this article.
October 2017: Journal of Oncology Pharmacy Practice
https://www.readbyqxmd.com/read/28764597/letters-about-published-papers
#2
Jim Siderov
No abstract text is available yet for this article.
October 2017: Journal of Oncology Pharmacy Practice
https://www.readbyqxmd.com/read/27559020/a-rare-case-of-blastic-plasmacytoid-dendritic-cell-neoplasm-with-deletion-7q-31-in-the-setting-of-heavy-pre-treatment-with-alkylating-chemotherapy
#3
Varinder Kaur, Arjun Swami, Atrash Shebli, Sara Shalin, Muthu Veeraputhiran, Peter Emanuel, Yogesh Jethava
Blastic plasmacytoid dendritic cell neoplasm is rare myeloid malignancy clinically characterized by non-pruritic, violaceous and papulo-nodular skin lesions, together with bone marrow and lymph node involvement. Histologically, there is infiltration of dermis by neoplastic mono-nuclear CD4, CD56, CD123 co-expressing cells with epidermal sparing. Most commonly blastic plasmacytoid dendritic cell neoplasm presents as a de-novo condition, and treatment-related blastic plasmacytoid dendritic cell neoplasm is a rare phenomenon...
October 2017: Journal of Oncology Pharmacy Practice
https://www.readbyqxmd.com/read/27543094/effect-of-single-agent-high-dose-methotrexate-related-acute-kidney-injury-on-length-of-hospitalization-and-relative-dose-intensity-in-adult-patients-with-central-nervous-system-lymphoma
#4
Jennifer S Steward, Heather M Bullard, Timothy J O'Rourke, Alan D Campbell, Brett T Brinker, Kathleen J Yost, Amy C Vanderwoude, William L Scott, Polly E Kintzel
Purpose Grade ≥3 adverse effects prolong hospitalization and reduce chemotherapy dose intensity. The purpose of this study was to evaluate the rate and severity of high-dose methotrexate-related acute kidney injury and analyze its effect on hospital length of stay and relative chemotherapy dose intensity. Methods This was a retrospective cohort analysis. Patients receiving ≥1 dose of high-dose methotrexate were analyzed for acute kidney injury and length of stay. Patients receiving ≥6 cycles of induction therapy were included in the analysis of relative chemotherapy dose intensity...
October 2017: Journal of Oncology Pharmacy Practice
https://www.readbyqxmd.com/read/27530243/drug-drug-interactions-of-cytostatics-with-regular-medicines-in-lung-cancer-patients
#5
Florentine Mv Rompelman, Adrianus Aj Smit, Eric Jf Franssen, Mirjam Crul
Background Lung cancer patients have a high risk for drug-drug interactions, as they use numerous types of concomitant medicines including antineoplastic agents, cancer treatment co-medication, and medicines aimed at several types of comorbidities. Objective The primary objective of this study is to determine the incidence and the clinical relevance of the drug-drug interactions between antineoplastic agents and regular medication used by lung cancer patients. Secondary objectives are (i) to determine the effectiveness of the medication review by the hospital pharmacists concerned, (ii) to establish which patients are most at risk of drug-drug interactions and (iii) to determine whether physicians comply with advice given by hospital pharmacists...
October 2017: Journal of Oncology Pharmacy Practice
https://www.readbyqxmd.com/read/27530242/paclitaxel-pre-medication-a-comparison-of-two-steroid-pre-medication-protocols
#6
Ayberk Yenilmez, Annette P Hood, Lien H Nguyen, Man Y Merl
Purpose To evaluate and compare the rate of hypersensitivity reactions between two low-dose steroid pre-medication regimens for paclitaxel-based treatments. Methods This was a single-center, retrospective, descriptive study, comparing the incidence of hypersensitivity reactions in two different dexamethasone pre-medication regimens that took place between July 2013 to December 2014. Patients who were paclitaxel-naïve with a diagnosis of breast or gynecological cancers were included. Patients in the early termination protocol were pre-medicated with a standard pre-medication regimen and if tolerated with no hypersensitivity reaction occurrence, all pre-medications were discontinued after the first two infusions...
October 2017: Journal of Oncology Pharmacy Practice
https://www.readbyqxmd.com/read/27511215/sustained-clinico-radiologic-response-to-anti-cytotoxic-t-lymphocyte-antigen-4-antibody-therapy-in-metastatic-myxoid-liposarcoma
#7
Constantin A Dasanu
Rarity and heterogeneity of sarcomas pose significant challenges in terms of developing new therapies. Therefore, efforts towards studying immunotherapy in sarcomas may provide hope for effective control of this group of devastating cancers. A sustained clinico-radiologic response to the anti-cytotoxic T lymphocyte antigen 4 antibody ipilimumab in a patient with metastatic myxoid liposarcoma is reported. Although the patient was treated with this agent for metastatic melanoma, both his metastatic cancers - melanoma and sarcoma - meaningfully responded to this agent...
October 2017: Journal of Oncology Pharmacy Practice
https://www.readbyqxmd.com/read/27466225/safe-administration-of-docetaxel-after-weekly-paclitaxel-induced-acute-pancreatitis
#8
Jean-Philippe Adam, Philippe Gauthier, Nathalie Letarte
Acute pancreatitis is an inflammatory process of the pancreas that can be mild to severe. It requires biochemical or radiologic evidence to establish the diagnosis. Only few chemotherapy agents are directly linked to acute pancreatitis. In this case report, we describe a patient who developed a mild acute pancreatitis on weekly paclitaxel with a positive dechallenge and rechallenge. A 57-year-old woman with advanced ovarian cancer started chemotherapy with carboplatin (AUC 5 every three weeks) and weekly paclitaxel (80 mg/m(2) on days 1, 8, and 15)...
October 2017: Journal of Oncology Pharmacy Practice
https://www.readbyqxmd.com/read/27388159/utilization-and-evaluation-of-noncore-chemotherapy-regimens-within-an-academic-medical-center
#9
Jason R Jared, Mary S Mably, Rory Makielski, Michael P Reed, Michael J Fallon, Glenn Liu, Daniel Mulkerin, Natalie S Callander
Uniformity of evidence-based chemotherapy prescribing using approved, standard, or "core" regimens provides systems-based safety. Noncore chemotherapy regimens are non-standard-of-care regimens requested by physicians on a patient-by-patient basis. Chemotherapy Council, a Pharmacy & Therapeutics subcommittee, assesses all requests and determines approval status based upon submitted evidence and patient-specific factors. This study's purpose is to describe noncore chemotherapy regimens utilization, efficacy, and clinical outcomes in patients receiving noncore chemotherapy regimens...
October 2017: Journal of Oncology Pharmacy Practice
https://www.readbyqxmd.com/read/27357816/expanding-the-armamentarium-for-chronic-lymphocytic-leukemia-a-review-of-novel-agents-in-the-management-of-chronic-lymphocytic-leukemia
#10
Bernard L Marini, Lisa Samanas, Anthony J Perissinotti
Treatment options for chronic lymphocytic leukemia, the most common leukemia in the United States, have expanded rapidly in recent years. While traditional chemoimmunotherapy still remains a mainstay for young, fit patients, a number of novel targeted therapies have emerged that have changed the therapeutic landscape. Two innovative anti-CD20 monoclonal antibodies, obinutuzumab and ofatumomamab, have demonstrated activity in chronic lymphocytic leukemia and represent well-tolerated options in upfront management of elderly patients or in those with significant comorbidities...
October 2017: Journal of Oncology Pharmacy Practice
https://www.readbyqxmd.com/read/27357815/bortezomib-therapy-related-lung-disease-in-a-patient-with-light-chain-amyloidosis-a-case-report
#11
Erich Balsman
Bortezomib was the first antineoplastic proteasome inhibitor and is currently indicated for the treatment of hematologic malignancies including multiple myeloma and mantle cell lymphoma. This report describes a 57-year-old patient with light chain (primary) amyloidosis receiving weekly subcutaneous bortezomib injections who presented with recurrent hypoxemia and interstitial pneumonitis. Following the failure of conventional therapy, the patient responded rapidly to high-dose intravenous methylprednisolone...
October 2017: Journal of Oncology Pharmacy Practice
https://www.readbyqxmd.com/read/27306885/evolution-of-ramucirumab-in-the-treatment-of-cancer-a-review-of-literature
#12
A Vennepureddy, P Singh, R Rastogi, J P Atallah, T Terjanian
Ramucirumab is a recombinant human monoclonal antibody and is used in the treatment of advanced malignancies. Its mechanism of action is by inhibiting angiogenesis in tumor cells by targeting the vascular endothelial growth factor receptor 2. United States Food and Drug Administration (FDA) approved it initially in 2014 for the treatment of advanced gastric or gastro-esophageal junction adenocarcinoma and metastatic non-small cell lung carcinoma. It was approved by FDA in 2015 for the treatment of advanced colorectal cancer...
October 2017: Journal of Oncology Pharmacy Practice
https://www.readbyqxmd.com/read/27009803/safe-handling-of-oral-antineoplastic-medications-focus-on-targeted-therapeutics-in-the-home-setting
#13
Yaakov Cass, Thomas H Connor, Alexander Tabachnik
Introduction With the growing number of oral targeted therapies being approved for use in cancer therapy, the potential for long-term administration of these drugs to cancer patients is expanding. The use of these drugs in the home setting has the potential to expose family members and caregivers to them either through direct contact with the drugs or indirectly by exposure to the parent compounds and/or their active metabolites in contaminated patients' waste. Methods A systematic literature review was performed and the known adverse health effect of 32 oral targeted therapeutics is summarized...
July 2017: Journal of Oncology Pharmacy Practice
https://www.readbyqxmd.com/read/28077045/association-of-time-to-antibiotics-and-clinical-outcomes-in-adult-hematologic-malignancy-patients-with-febrile-neutropenia
#14
Allison R Butts, Christina Carracedo Bachmeier, Emily V Dressler, Meng Liu, Ann Cowden, Jeff Talbert, Val R Adams
Objective The objective of this study was to determine the clinical impact of time to antibiotic administration in adult inpatients who have hematologic malignancies and develop febrile neutropenia. Methods A retrospective chart review was conducted to screen for all febrile neutropenia events amongst adult hematologic malignancy patients between 1 January 2010 and 1 September 2014. All included patients were admitted to the hospital at the time of fever onset, having been admitted for a diagnosis other than febrile neutropenia...
June 2017: Journal of Oncology Pharmacy Practice
https://www.readbyqxmd.com/read/27799607/adherence-with-capecitabine-a-population-based-analysis-based-on-prescription-refill-data
#15
Laurel Kovacic, Neil de Haan, Mário L de Lemos, Kimberly Schaff, Susan Walisser
Background Patient adherence is important with the increasing use of oral anticancer drugs. Recent studies reported different capecitabine adherence rates based on self-reporting and microelectronic monitoring of the medication bottle. Patient's awareness of being monitored may confound these results. Prescription records provide a larger and more objective dataset for adherence investigation. We report the use of computer algorithm and manual review of prescription and medical documentation to determine the rate of capecitabine adherence...
June 2017: Journal of Oncology Pharmacy Practice
https://www.readbyqxmd.com/read/27000278/breast-cancer-patient-with-everolimus-induced-angioedema-a-rare-occurrence-with-potential-for-serious-consequences
#16
Neil Roe, Jennifer D Twilla, Benjamin Duhart, Brian Wheeler
Background The development of angioedema is a rare yet serious clinical event that may develop due to an adverse drug reaction. Rapid recognition and treatment of this adverse reaction is critical for optimal patient outcomes; however, prevention of this occurrence is preferred. Case report A 59-year-old woman presented to the emergency department with lingual angioedema caused by the addition of everolimus to her medication regimen. The patient improved after withdrawal of the offending agent and standard treatment...
June 2017: Journal of Oncology Pharmacy Practice
https://www.readbyqxmd.com/read/26988246/improving-adherence-to-the-epic-beacon-ambulatory-workflow
#17
Ellen Chackunkal, Vishnuprabha Dhanapal Vogel, Meredith Grycki, Diana Kostoff
Computerized physician order entry has been shown to significantly improve chemotherapy safety by reducing the number of prescribing errors. Epic's Beacon Oncology Information System of computerized physician order entry and electronic medication administration was implemented in Henry Ford Health System's ambulatory oncology infusion centers on 9 November 2013. Since that time, compliance to the infusion workflow had not been assessed. The objective of this study was to optimize the current workflow and improve the compliance to this workflow in the ambulatory oncology setting...
June 2017: Journal of Oncology Pharmacy Practice
https://www.readbyqxmd.com/read/26988245/acute-encephalopathy-with-combination-dabrafenib-trametinib-therapy
#18
Jalyn Cooper, Dheeraj Kodali, Gerald M Higa
Biomarkers have improved the clinical application of numerous targeted agents used to treat solid tumors. In melanoma, the finding that approximately 60% of tumor cells harbor specific Val600 mutations of BRAF has increased the likelihood of response to certain agents aimed at inhibiting the mutant kinase. While dabrafenib is an effective anti-tumor agent with acceptable tolerability in patients with BRAF-mutated melanoma, we report the development (and outcome) of a previously unpublished acute toxic reaction observed in a patient receiving the drug...
June 2017: Journal of Oncology Pharmacy Practice
https://www.readbyqxmd.com/read/26983449/observational-study-of-trastuzumab-related-cardiotoxicity-in-early-and-metastatic-breast-cancer
#19
L R Grazziotin, P D Picon
Introduction Trastuzumab-related cardiotoxicity has been a major concern in clinical practice, since observational studies have shown higher incidences than that reported in clinical trials. We aim to measure the incidence of trastuzumab-related cardiotoxicity in patients with early and metastatic breast cancer in the south of Brazil. Methods Multicenter prospective observational study, which included 109 patients with early or metastatic HER-2+ breast cancer undergoing any trastuzumab-based regimen. Cardiac events were measured by transthoracic echocardiography assessments and by signs and symptoms of heart failure...
June 2017: Journal of Oncology Pharmacy Practice
https://www.readbyqxmd.com/read/26970572/risk-of-graft-versus-host-disease-with-rituximab-containing-conditioning-regimens-in-allogeneic-hematopoietic-stem-cell-transplant
#20
Bernard L Marini, Denise Markstrom, David Frame
Graft-versus-host disease represents a major cause of morbidity and mortality in allogeneic hematopoietic stem cell transplant patients. There is growing evidence that B lymphocytes may play a role in the pathogenesis of acute graft-versus-host disease. The purpose of this retrospective cohort study was to evaluate the efficacy of rituximab-containing conditioning regimens in decreasing graft-versus-host disease in allogeneic hematopoietic stem cell transplant patients who received standardized tacrolimus-based graft-versus-host disease prophylaxis regimens...
June 2017: Journal of Oncology Pharmacy Practice
journal
journal
32324
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"